Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-06-23 Sale | 2020-06-25 8:07 pm | Principia Biopharma Inc. | PRNB | Babler Martin President, CEO | 15,000 | $61.86 | $927,889 | 144,072 (Indirect Direct) | View |
| 2020-03-03 Sale | 2020-03-05 5:21 pm | Principia Biopharma Inc. | PRNB | Babler Martin President, CEO | 15,000 | $63.47 | $952,083 | 239,179 (Indirect Direct) | View |
| 2019-12-17 Sale | 2019-12-19 9:06 pm | Principia Biopharma Inc. | PRNB | Babler Martin President, CEO | 29,500 | $53.07 | $1,565,455 | 18,355 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-16 Option Award | 2023-06-21 4:11 pm | N/A 2033-06-15 | Prelude Therapeutics Inc | PRLD | Babler Martin Director | 23,500 | $0 | 23,500 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 4:24 pm | N/A 2033-06-07 | Neoleukin Therapeutics Inc. | NLTX | Babler Martin Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:13 pm | N/A 2032-06-16 | Prelude Therapeutics Inc | PRLD | Babler Martin Director | 31,293 | $0 | 31,293 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-16 6:22 pm | N/A 2032-05-11 | Neoleukin Therapeutics Inc. | NLTX | Babler Martin Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-07-19 Option Award | 2021-07-20 8:30 pm | N/A 2031-07-18 | Prelude Therapeutics Inc | PRLD | Babler Martin Director | 36,400 | $0 | 36,400 (Direct) | View |
| 2021-05-11 Option Award | 2021-05-13 5:36 pm | N/A 2031-05-10 | Neoleukin Therapeutics Inc. | NLTX | Babler Martin Director | 25,000 | $0 | 25,000 (Direct) | View |
Ownership | 2021-01-06 9:39 pm | N/A N/A | Omega Alpha SPAC | OMEG | Babler Martin Director | 0 | $0 | 35,000 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:07 pm | N/A 2022-12-29 | Principia Biopharma Inc. | PRNB | Babler Martin President, CEO | 1,048,147 | $0 | 0 (Indirect) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:07 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Babler Martin President, CEO | 58,557 | $100 | 0 (Direct) | View |
| 2020-09-08 Option Award | 2020-09-10 4:28 pm | N/A 2030-09-08 | Neoleukin Therapeutics Inc. | NLTX | Babler Martin Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2020-06-23 Exercise | 2020-06-25 8:07 pm | N/A 2023-10-23 | Principia Biopharma Inc. | PRNB | Babler Martin President, CEO | 15,000 | $0 | 144,072 (Direct) | View |
| 2020-06-23 Exercise | 2020-06-25 8:07 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Babler Martin President, CEO | 15,000 | $2.9977 | 144,072 (Direct) | View |
| 2020-03-05 Option Award | 2020-03-05 5:21 pm | N/A 2030-03-04 | Principia Biopharma Inc. | PRNB | Babler Martin President, CEO | 200,000 | $0 | 239,179 (Direct) | View |
| 2020-02-10 Gift | 2020-03-05 5:21 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Babler Martin President, CEO | 1,159 | $0 | 239,179 (Direct) | View |
| 2019-12-27 Ownership | 2020-02-14 5:58 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Babler Martin President, CEO | 1,500 | $0 | 72,534 (Direct) | View |
Ownership | 2020-02-14 5:58 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Babler Martin President, CEO | 0 | $0 | 72,534 (Indirect) | View |